STAT3 Is a Biologically Relevant Therapeutic Target in H3K27M-Mutant Diffuse Midline Glioma

0
66
Researchers screened a library of drugs either FDA-approved or in clinical trial using a library of patient-derived H3K27M-mutant diffuse midline glioma cell lines with cell viability as the outcome.
[Neuro-Oncology]
Abstract